Plastic and Reconstructive Surgery, Global Open (Oct 2021)
Cost-effectiveness of Erenumab versus Surgical Trigger Site Deactivation for the Treatment of Migraine Headaches: A Systematic Review
Abstract
No abstracts available.
Plastic and Reconstructive Surgery, Global Open (Oct 2021)